Prism Johnson Limited (PRSMJOHNSN)
Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Q1FY27 results (unaudited):
Consolidated:
Revenue 18.4bn +2.7% y-y (17.96bn)
EBITDA 2.21bn +26.6% y-y (1.74bn)
EBITDA margin 12.0% (9.7%) +226 bps y-y
PAT 0.94bn nm y-y (0.02bn)
Commentary: Prism Johnson Limited delivered one of its best quarterly performances, driven by robust execution in H&R Johnson and Prism RMC, with resilience in Prism Cement amid market softness. The quarter faced external headwinds including elevated fuel costs and inflation, yet disciplined cost management and operational efficiencies enabled healthy profitability. The company completed divestment of Raheja QBE General Insurance, sharpening focus on core building materials and accelerating deleveraging.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 PRSMJOHNSN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add PRSMJOHNSN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Prism Johnson Limited
Important.
The summary above is generated automatically from Prism Johnson Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.